Jesus Corria-Osorio

6PUBLICATIONS
73CO-AUTHORS
Tumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 22, 2026
The transcription factor IRF8 drives tumor-specific exhaustion in CD8+ T cells.

|May 20, 2025
Age-associated nicotinamide adenine dinucleotide decline drives CAR-T cell failure.

Helen Carrasco Hope, Jana de Sostoa, Pierpaolo Ginefra

|Jul 18, 2024
Cryoablation Does Not Significantly Contribute to Systemic Effector Immune Responses in a Poorly Immunogenic B16F10 Melanoma Model.

Chakradhar Yakkala, Jesus Corria-Osorio, Lana Kandalaft

|Apr 24, 2024
PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function.

Matteo Morotti, Alizee J Grimm, Helen Carrasco Hope

|Feb 02, 2024
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T-myeloid cell networks in melanoma.

David Barras, Eleonora Ghisoni, Johanna Chiffelle

|Apr 20, 2023
Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8+ T cells.

Jesus Corria-Osorio, Santiago J Carmona, Evangelos Stefanidis

Pageof 1

Frequent Collaborators

4 joint publications

George Coukos

3 joint publications

Lana Kandalaft

3 joint publications

Ping-Chih Ho

2 joint publications

Helen Carrasco Hope